Sunshine Biopharma (SBFM) Receivables (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly Receivables came in at $4.0 million in Q1 2026, up 16.44% YoY from $3.4 million in Q1 2025, and up 15.95% on a QoQ basis from $3.5 million in Q4 2025.
Sunshine Biopharma (SBFM) Receivables (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 11 years of Receivables data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Receivables rose 16.44% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 16.44% YoY) and the FY2025 annual result came in at $3.5 million, down 10.56% from the prior year.
- Receivables grew to $4.0 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $4.2 million in Q3 2025 to a low of $22.0 in Q3 2022.
- A 5-year average of $2.5 million and a median of $2.8 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables sank 98.05% — and 2023, when it jumped 9245895.45%.
- Tracing SBFM's Receivables over 5 years: stood at $1.9 million in 2022, then jumped by 33.48% to $2.6 million in 2023, then soared by 51.56% to $3.9 million in 2024, then declined by 10.56% to $3.5 million in 2025, then increased by 15.95% to $4.0 million in 2026.
- The last three Receivables figures came in at $4.0 million (Q1 2026), $3.5 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 4.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.04 Mn |
| Mar 31, 2026 | 4.01 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 22.00 |
| Jun 30, 2022 | 24.00 |
| Mar 31, 2022 | 24.00 |
| Dec 31, 2021 | 7,798.00 |
| Sep 30, 2021 | 1,129.00 |